ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0503

Gain-of-Function WNK4 Rescues Cell Cycle and Proliferation Defects in ClC-Kb-Deficient Thick Ascending Limb

Session Information

Category: Fluid, Electrolytes, and Acid-Base Disorders

  • 1101 Fluid, Electrolyte, and Acid-Base Disorders: Basic

Authors

  • Hsieh, Chiao-Hui, The University of Iowa Roy J and Lucille A Carver College of Medicine, Iowa City, Iowa, United States
  • Chen, Yu Jen, Taichung Veterans General Hospital, Taichung, Taichung City, Taiwan
  • Morrison, Emily, The University of Iowa Roy J and Lucille A Carver College of Medicine, Iowa City, Iowa, United States
  • Huang, Chou-Long, The University of Iowa Roy J and Lucille A Carver College of Medicine, Iowa City, Iowa, United States
  • Cheng, Chih-Jen, The University of Iowa Roy J and Lucille A Carver College of Medicine, Iowa City, Iowa, United States
Background

ClC-Kb deficiency impairs the transport and development of the thick ascending limbs (TALs) and distal convoluted tubules (DCTs). Conversely, activation of with-no-lysine 4 (WNK4) kinase stimulates salt reabsorption and cell hypertrophy in DCTs. This study investigates how ClC-Kb deficiency affects gene expression and cellular state in TALs, and whether gain-of-function WNK4D561A/+ can reverse these changes.

Methods

TALs isolated from Clc-k2 (mouse ClC-Kb ortholog)-knockout (Clc-k2-/-), Wnk4D561A/+ rescued (Wnk4D561A/+ /Clc-k2-ko), and control mice were subjected to transcriptome analysis. Primary cultured TAL or HEK cells overexpressing ClC-Kb/barttin were treated with NPPB, a chloride channel blocker, or vehicle for cell cycle and proliferation assays. Clc-k2-/- mice were interbred with WNK4D561A/+ knockin or Kcc4-knockout (Kcc4-/-) mice to decide whether WNK4D561A/+ and Kcc4 improve the phenotype of Clc-k2-/- mice.

Results

Deletion of Clc-k2 led to transcriptomic changes in cell cycle regulation, cell proliferation, and early injury responses in TALs. Primary cultured Clc-k2-/- TALs proliferated 40% less efficiently than wild-type cells. NPPB induced G2-M cell cycle arrest and impaired cell proliferation in ClC-Kb-overexpressed HEK cells. The phenotype of WNK4D561A/+/Clc-k2-/- mice was analyzed and compared to Clc-k2-/- mice receiving salt supplementation. While both approaches prevented neonatal death in Clc-k2-/- mice, only WNK4D561A/+/Clc-k2-/- mice showed improvements in growth, activity of sodium cotransporters, urine concentration, and renal fibrosis. Moreover, WNK4D561A/+ corrected the transcriptomic alterations induced by Clc-k2 deficiency, indicating that enhancing transport activity is achievable and therapeutic in Clc-k2-deficient renal tubules. Double deletion of Clc-k2 and Kcc4 exacerbated neonatal mortality, growth delay, and renal salt wasting, suggesting that Kcc4 partially compensates for Clc-k2 in the TAL/DCT.

Conclusion

Clc-k2 regulates the cell cycle and proliferation of TALs, likely by affecting transport activity and cellular growth. The gain-of-function Wnk4 significantly improves the phenotype, renal histology, and cell proliferation of Clc-k2-/- mice through restoring salt reabsorption in TALs/DCTs. Kcc4 provides alternative basolateral chloride access for Clc-k2-deficient TALs/DCTs.

Funding

  • NIDDK Support

Digital Object Identifier (DOI)